100 Union Valley Road, Suite 120

Oak Ridge, TN 37830

P: 865-220-8630

F: 865-425-1269

4605 Papermill Drive

Knoxville, TN 37909

P: 865-584-3926

F: 865-584-3645

601 Wall Street

Sevierville, TN 37862

P: 865-429-5800

F: 865-429-5840

© 2014 by NetGain Mobile Diagnostics. Proudly created with Wix.com


January 24, 2020

After years of research and clinical trials, the Multidisciplinary Association for Psychedelic Studies (MAPS) is convincing government officials and patients that the drug can be beneficial in the treatment of Post-Traumatic Stress Disorder (PTSD). MAPS recently announced they had received expanded access approval for the continued research into MDMA-assisted Psychotherapy for PTSD. This is a major step toward making the drug legal for medical purposes.The Food and Drug Administration (FDA) recognition of the drug's effectiveness for trauma survivors furthers the organization's effort. If Phase 3 trials are effective, the therapy will be approved.


"We are looking at possible FDA approval for treatment at the end of 2021, and the accessibility of treatment in clinics by 2022," said Brad Burge, a spokesperson for MAPS.


Results of the research done by MAPS have been encouraging. So encouraging that the results were published in The Lancet Psychiatry in 2018. According to the publication, a study of 26 veterans, firefighters, and police officers with service-related PTSD found that two of the three testing groups responded positively to MDMA-assisted Psychotherapy and had "significantly greater decreases in PTSD symptom severity."


SOURCE: Andrew Keiper, Associate Producer with the Investigative Unit, Fox News

Please reload

Featured Posts

NetGain Mobile Diagnostics is offering Tetanus/Diphtheria shots (Td Vaccine) for $35.00 each, that's a 20% discount, until 10/20/2015.  The Td vaccine...

It's Tetanus Time in Tennessee!

September 23, 2015

Please reload

Recent Posts

January 24, 2020

December 27, 2019

November 5, 2019

Please reload

Please reload

Search By Tags
Please reload